Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.

Cancer Gene Ther · 2011 · PMC3007590 · PMID 20829890

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significanceP >0.15not close (p > 0.1)

The injection of the prodrug resulted in reduced tumor size in all subgroups when compared with the corresponding non-prodrug-treated animals, although the difference did not reach statistical significance in those groups injected with PBS or the GLV-1h43 strain ( P >0.15).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.